ALOG-PROPIVERINE DIN 02563126
Health Canada record
| Active ingredient(s) | PROPIVERINE HYDROCHLORIDE 45 MG |
|---|---|
| Dosage form | Capsule (Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G04BD06 PROPIVERINE |
| Original market date | |
| Current status date | 25-Nov-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Analog Pharma Canada Inc. — licence 3-002868, currently licensed, last inspection rating C (2024-06-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PROPIVERINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02563118 | ALOG-PROPIVERINE | ANALOG PHARMA CANADA INC. | Capsule (Extended-Release) | PROPIVERINE HYDROCHLORIDE 30 MG | Approved |
| 02563134 | ALOG-PROPIVERINE PEDIATRIC | ANALOG PHARMA CANADA INC. | Tablet | PROPIVERINE HYDROCHLORIDE 5 MG | Approved |
| 02460262 | MICTORYL | DUCHESNAY INC | Capsule (Extended-Release) | PROPIVERINE HYDROCHLORIDE 30 MG | Marketed |
| 02460270 | MICTORYL | DUCHESNAY INC | Capsule (Extended-Release) | PROPIVERINE HYDROCHLORIDE 45 MG | Marketed |
| 02460289 | MICTORYL PEDIATRIC | DUCHESNAY INC | Tablet | PROPIVERINE HYDROCHLORIDE 5 MG | Marketed |